Other sexually transmitted chlamydial diseases

AB1_CHLAMYDIA_OTHER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A56 Cause of death: ICD-10 — A56 2 out of 7 registries used, show all original rules.	2996
4. Check minimum number of events None	2996
5. Include endpoints None	2996
6. Filter based on genotype QC (FinnGen only)	2996

Control definitions (FinnGen only)

Control exclude: AB1_SEXUAL_TRANSMISSION

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_CHLAMYDIA_OTHER
CONTROL_EXCLUDE	AB1_SEXUAL_TRANSMISSION
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A56
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A56
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other sexually transmitted chlamydial diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27355	14515	12595
Only index persons	26769	14337	12432
Unadjusted period prevalence (%)
Whole population	0.38	0.42	0.35
Only index persons	0.50	0.53	0.47
Median age at first event (years)
Whole population	23.92	22.45	25.51
Only index persons	23.86	22.45	25.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2996	1956	1040
Unadjusted period prevalence (%)	0.59	0.67	0.46
Median age at first event (years)	24.96	23.14	28.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2670: Matched controls
26701

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

796.7

323.0

2220

165

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

25.9

323.0

1610

1480

A63.0

ICD-10 Finland

Anogenital (venereal) warts

21.3

308.9

470

265

A56.3

ICD-10 Finland

Chlamydial infection of anus and rectum

374.3

242.6

241

A56.2

ICD-10 Finland

Chlamydial infection of genitourinary tract, unspecified

46.4

144.6

178

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

12.7

112.0

206

174

N74.4*A56.1

ICD-10 Finland

Female chlamydial pelvic inflammatory disease

270.8

102.5

104

A54.6

ICD-10 Finland

Gonococcal infection of anus and rectum

+∞

101.7

A54.5

ICD-10 Finland

Gonococcal pharyngitis

+∞

101.7

A54.0

ICD-10 Finland

Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

90.2

93.7

104

A56.4

ICD-10 Finland

Chlamydial infection of pharynx

144.5

79.4

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

35.8

77.2

100

N76.0

ICD-10 Finland

Acute vaginitis

3.2

69.7

420

1487

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.8

69.3

524

2155

A51.0

ICD-10 Finland

Primary genital syphilis

643.2

64.1

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

8.5

63.2

143

177

Y25

ICPC

Fear sexually transm disease male

4.8

59.5

209

461

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

58.4

702

3658

A56.1

ICD-10 Finland

Chlamydial infection of pelviperitoneum and other genitourinary organs

122.7

56.0

D06BB04

ATC

podophyllotoxin; topical

3.1

55.0

333

1172

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

3.9

54.7

245

682

Z29.2

ICD-10 Finland

Other prophylactic chemotherapy

70.4

54.3

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

58.6

53.7

R74

ICPC

Upper respiratory infection acute

1.9

49.1

1175

7927

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

3.2

48.4

283

967

J05AB01

ATC

aciclovir; systemic

2.2

47.0

567

2917

J05AB11

ATC

valaciclovir; oral

2.6

44.7

350

1441

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

3.6

40.3

190

550

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

53.1

39.6

LCH11

NOMESCO Finland

Pharmacologic abortion

2.7

38.5

291

1169

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.1

37.5

152

385

P01AB01

ATC

metronidazole; oral, rectal

1.8

36.5

934

6260

X23

ICPC

Fear sexually transm dis female

2.3

35.0

368

1753

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.5

33.5

288

1238

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

32.6

861

5777

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

31.5

750

4868

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

25.7

31.0

A51.9

ICD-10 Finland

Early syphilis, unspecified

+∞

30.3

X92

ICPC

Chlamydia infection genital female

3.7

30.1

136

380

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

30.0

373

1906

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.2

29.8

327

1584

J01DB01

ATC

cefalexin; oral

1.7

29.0

2139

18686

WW200

NOMESCO Finland

Immunization

4.1

28.7

116

294

SPAT1324

SPAT

Screening procedure

0.4

28.3

157

3387

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

27.6

331

1663

KGD10

NOMESCO Finland

Destruction of lesion of penis

273.7

26.8

TQW02

NOMESCO Finland

Removal of wart

97.7

26.7

ULA02

NOMESCO Finland

Kolposcopy

2.1

25.5

316

1607

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

3.2

25.4

140

457

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.0

25.2

356

1910

N05BA04

ATC

oxazepam; oral

1.7

25.1

591

3777

J01FA10

ATC

azithromycin; systemic

1.5

24.8

1652

13699

J02AC01

ATC

fluconazole; systemic

1.6

24.7

997

7357

W79

ICPC

Unwanted pregnancy

3.3

24.5

128

402

G01AA10

ATC

clindamycin; vaginal

1.9

24.2

376

2088

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

23.4

972

7197

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.9

23.3

258

R2110

NOMESCO Finland

Giving the first information

2.3

23.3

220

987

N05CF01

ATC

zopiclone; oral

1.7

22.4

511

3221

M01AB05

ATC

diclofenac; systemic, rectal

1.5

22.3

1450

11823

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.2

21.9

240

1154

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

37.5

20.8

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.7

20.6

146

561

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.6

988

7501

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

4.3

19.9

175

R4110

NOMESCO Finland

Physiotherapy

1.7

19.9

471

2990

N48.1

ICD-10 Finland

Balanoposthitis

4.5

19.7

158

WX110

SPAT

2.5

19.6

154

628

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

19.6

455

2871

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.7

19.6

486

3127

N05CF02

ATC

zolpidem; oral

1.8

19.0

382

2307

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

17.2

18.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

18.6

1511

12673

J01AA02

ATC

doxycycline; systemic

1.4

18.5

1564

13210

D73

ICPC

Gastroenteritis presumed infection

2.4

18.2

157

672

M03BX02

ATC

tizanidine; oral

1.4

18.1

1426

11860

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

18.1

861

6474

J01MA02

ATC

ciprofloxacin; systemic

1.5

18.0

656

4648

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

18.0

248

1310

SPAT1375

SPAT

Structural ultrasound screening, weeks 18+0-21+6

3.2

17.3

300

N06AX11

ATC

mirtazapine; oral

1.5

17.2

675

4857

R21

ICPC

Throat symptom/complaint

1.5

17.1

803

6005

EMB10

NOMESCO Finland

Tonsillectomy

1.8

17.1

304

1760

T74.1

ICD-10 Finland

Physical abuse

2.9

17.0

103

360

B86

ICD-10 Finland

Scabies

3.3

16.9

262

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

2.4

16.9

148

639

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

2.0

16.9

211

1075

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.4

16.8

252

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

16.8

629

4475

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

16.8

119

458

A55

ICD-10 Finland

Chlamydial lymphogranuloma (venereum)

+∞

16.7

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

16.5

590

4151

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

16.2

418

2708

D10

ICPC

Vomiting

1.8

16.1

285

1647

SPAT1373

SPAT

Combined screening in early pregnancy

2.5

16.1

132

553

D11

ICPC

Diarrhoea

1.7

15.6

394

2532

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

15.5

217

1152

Z20.6

ICD-10 Finland

Contact with and exposure to human immunodeficiency virus [HIV]

13.8

15.5

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

15.4

2392

22387

Z30

ICD-10 Finland

Contraceptive management

2.3

15.2

138

608

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

3.1

15.2

278

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.1

1947

17425

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

45.3

15.1

M54

ICD-10 Finland

Dorsalgia

1.7

15.0

308

1867

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

14.9

1056

8496

X14

ICPC

Vaginal discharge

2.5

14.9

118

484

N05AH04

ATC

quetiapine; oral

1.5

14.7

497

3439

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

14.7

162

784

N02AX02

ATC

tramadol; systemic, rectal

1.5

14.6

664

4906

A53.9

ICD-10 Finland

Syphilis, unspecified

150.8

14.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

14.4

490

3394

MAX99

NOMESCO Finland

Assistance to normal delivery

1.6

14.2

458

3129

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

14.2

483

3342

M01AE02

ATC

naproxen; oral, rectal

1.4

14.0

1374

11647

Y71

ICPC

Gonorrhoea male

75.5

13.6

N05BA12

ATC

alprazolam; oral

1.9

13.5

193

1036

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

13.3

353

2295

EB1SA

SPAT

2.4

13.3

117

509

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.7

13.3

346

M79.6

ICD-10 Finland

Pain in limb

1.4

13.2

690

5219

EB1AA

SPAT

2.3

13.2

127

576

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

13.1

495

3504

J01CA08

ATC

pivmecillinam; oral

1.4

13.0

920

7351

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

12.7

383

2570

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.7

12.7

297

1868

N70.0

ICD-10 Finland

Acute salpingitis and oophoritis

4.8

12.7

N06AB10

ATC

escitalopram; oral

1.4

12.6

615

4584

X58

ICD-10 Finland

Exposure to other specified factors

1.6

12.6

360

2385

Z01.7

ICD-10 Finland

Laboratory examination

1.8

12.5

243

1444

WX002

NOMESCO Finland

Sedation and analgesia

1.7

12.4

283

1768

S06.0

ICD-10 Finland

Concussion

1.7

12.4

260

1584

D06BB10

ATC

imiquimod; topical

2.3

12.2

113

507

O98.3

ICD-10 Finland

Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium

26.8

12.0

J03

ICD-10 Finland

Acute tonsillitis

2.2

12.0

124

584

J20

ICD-10 Finland

Acute bronchitis

1.9

12.0

191

1067

Z71.8

ICD-10 Finland

Other specified counselling

1.4

12.0

641

4860

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

11.9

502

3631

W12

ICPC

Contraception intrauterine

1.5

11.9

449

3175

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

11.8

423

B23.0

ICD-10 Finland

Acute HIV infection syndrome

65.2

11.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

11.6

1939

17619

R51

ICD-10 Finland

Headache

1.9

11.6

170

921

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

11.5

205

1186

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.5

470

3378

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

11.4

725

5655

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.2

290

1871

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

5.5

11.2

F43.0

ICD-10 Finland

Acute stress reaction

1.9

11.1

168

920

W01

ICPC

Question of pregnancy

3.0

11.0

215

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.2

10.9

178

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

10.9

363

2493

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

10.9

176

989

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.5

10.8

337

WX290

SPAT

2.3

10.8

414

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.4

10.8

525

3899

I78.1

ICD-10 Finland

Naevus, non-neoplastic

3.2

10.8

180

WX110

NOMESCO Finland

Local anesthesy

1.3

10.7

1817

16420

N02BE01

ATC

paracetamol; systemic, rectal

1.3

10.6

1920

17510

N87.0

ICD-10 Finland

Mild cervical dysplasia

2.5

10.4

327

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.6

10.2

287

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

10.2

241

1518

X15

ICPC

Vaginal symptom/complaint other

1.9

10.0

148

804

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.0

247

1574

O04

ICD-10 Finland

Medical abortion

3.9

10.0

105

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

10.0

102

478

WX892

NOMESCO Finland

Monitored bed care

2.1

9.9

114

564

N06AB04

ATC

citalopram; systemic

1.5

9.9

410

2949

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

9.8

345

2391

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

9.8

243

1549

H01.0

ICD-10 Finland

Blepharitis

1.9

9.7

132

697

Z37.0

ICD-10 Finland

Single live birth

1.5

9.7

393

2812

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

9.7

437

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

9.7

123

634

N01

ICPC

Headache

1.5

9.6

373

2644

D01

ICPC

Abdominal pain/cramps general

1.5

9.6

307

2086

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

2.3

9.6

375

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

9.5

172

1003

A51.5

ICD-10 Finland

Early syphilis, latent

+∞

9.4

A98

ICPC

Health maint/preventive medicine

2.0

9.4

2601

25328

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

9.4

394

2839

WX320

NOMESCO Finland

Spinalanesthesy

1.5

9.3

354

2496

R51.80

ICD-10 Finland

Headache

1.4

9.2

412

3001

H10

ICD-10 Finland

Conjunctivitis

1.8

9.2

172

1010

W14

ICPC

Contraception female other

1.6

9.2

272

1813

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

9.2

555

4276

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

9.0

142

791

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

3.7

9.0

100

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

9.0

249

1636

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

9.0

253

1665

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

9.0

143

798

U72

ICPC

Urethritis

2.7

8.9

218

M01AH05

ATC

etoricoxib; oral

1.3

8.9

1128

9676

U71

ICPC

Cystitis/urinary infection other

1.9

8.9

127

685

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

8.8

121

2015

F32

ICD-10 Finland

Depressive episode

1.7

8.8

177

1067

N03AX16

ATC

pregabalin; oral

1.5

8.7

329

2316

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

8.7

185

J02AC02

ATC

itraconazole; systemic

1.5

8.7

278

1887

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

8.7

1261

10999

HMAK

NOMESCO Finland

0.6

8.7

151

2379

ZXC10

NOMESCO Finland

Use of laser

3.3

8.7

130

U13

ICPC

Bladder symptom/complaint other

2.6

8.6

234

TQW99

NOMESCO Finland

Other minor procedure on skin

2.6

8.6

228

I84

ICD-10 Finland

Hemorrhoids

2.7

8.4

202

A52.1

ICD-10 Finland

Symptomatic neurosyphilis

+∞

8.3

S72

ICPC

Scabies/other acariasis

3.8

8.3

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

8.3

714

8601

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.3

8.3

322

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

8.3

139

794

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

2.3

8.2

335

D09

ICPC

Nausea

1.7

8.2

151

888

M79.1

ICD-10 Finland

Myalgia

1.5

8.1

290

2017

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

33.4

8.1

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

8.0

521

4048

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

8.0

776

6394

C07AA05

ATC

propranolol; systemic

1.4

8.0

450

3414

N34.1

ICD-10 Finland

Nonspecific urethritis

8.9

8.0

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

5.9

8.0

N30

ICD-10 Finland

Cystitis

1.7

8.0

179

1114

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

8.0

479

T51.0

ICD-10 Finland

Toxic effect: Ethanol

3.6

7.9

AA1AD

NOMESCO Finland

CT of head and brain

1.5

7.9

256

1743

RD211

NOMESCO Finland

0.2

7.8

386

R83

ICPC

Respiratory infection other

1.3

7.8

845

7069

ZXA05

NOMESCO Finland

Left side

1.5

7.8

290

2037

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

7.8

1199

10482

N06AB03

ATC

fluoxetine; oral

1.5

7.7

239

1612

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

7.6

1301

11497

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.9

7.6

520

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

7.5

371

2752

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.5

335

2437

SPAT1262

SPAT

Handing over of treatment supplies

0.6

7.5

1663

B36.0

ICD-10 Finland

Pityriasis versicolor

2.5

7.4

221

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

7.4

806

6738

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.4

847

7126

Z01.2

ICD-10 Finland

Dental examination

1.3

7.4

1045

9025

ZXA10

NOMESCO Finland

Bilateral

1.5

7.3

259

1798

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.3

1585

14383

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.5

7.3

982

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

7.3

341

2504

M54.5

ICD-10 Finland

Low back pain

1.3

7.2

721

5954

A74.9

ICD-10 Finland

Chlamydial infection, unspecified

15.8

7.2

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.6

7.2

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.4

7.2

397

3000

D06

ICPC

Abdominal pain localized other

1.6

7.2

196

1286

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

2.1

7.2

368

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.9

7.2

S29

ICPC

Skin symptom/complaint other

1.5

7.1

287

2047

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.5

7.1

229

1558

SPAT1182

SPAT

Ultrasound examination of uterus, appendages and lower abdomen

2.7

7.1

163

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.0

7.1

411

Z35.6

ICD-10 Finland

Supervision of very young primigravida

5.3

7.1

M25.5

ICD-10 Finland

Pain in joint

1.3

7.0

554

4425

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.4

7.0

238

Z72.1

ICD-10 Finland

Alcohol use

3.1

7.0

113

Z72.0

ICD-10 Finland

Tobacco use

2.3

6.9

250

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

6.9

134

803

J01EA01

ATC

trimethoprim; systemic

1.3

6.9

446

3459

LCH03

NOMESCO Finland

Evacuation of products of conception and curettage of uterus

2.6

6.8

189

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

6.8

695

5749

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.0

6.8

377

L03

ICPC

Low back symptom/complaint

1.3

6.8

509

4037

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.8

184

1207

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.7

379

2874

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

6.7

160

1012

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

6.7

118

683

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.4

6.7

212

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

6.6

108

611

W19

ICD-10 Finland

Unspecified fall

1.6

6.6

162

1036

MAA40

NOMESCO Finland

Puncture of fetus

3.0

6.6

118

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

4.0

6.6

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.0

6.6

395

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

3.9

6.6

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.8

6.6

115

668

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

6.6

201

1355

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

6.5

139

856

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.2

6.5

267

K96

ICPC

Haemorrhoids

2.3

6.5

235

SPAT1371

SPAT

Assessment of need for induced abortion

3.0

6.5

119

A01

ICPC

Pain general/multiple sites

1.7

6.5

123

730

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

6.5

259

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

6.5

505

6193

U02

ICPC

Urinary frequency/urgency

1.5

6.5

240

1683

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.4

611

5004

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

6.4

319

2365

A56.8

ICD-10 Finland

Sexually transmitted chlamydial infection of other sites

70.0

6.4

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

6.4

183

1211

Z71.1

ICD-10 Finland

Person with feared complaint in whom no diagnosis is made

3.0

6.4

115

H02AB07

ATC

prednisone; oral

1.5

6.3

194

1308

S09.2

ICD-10 Finland

Traumatic rupture of ear drum

6.6

6.3

A60.9

ICD-10 Finland

Anogenital herpesviral infection, unspecified

8.2

6.3

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

6.3

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.2

435

3412

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

6.2

477

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.2

532

4292

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

6.2

370

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

6.2

250

1786

K05.22

ICD-10 Finland

Acute pericoronitis

1.5

6.2

235

1661

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

6.1

360

2747

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

6.1

196

1332

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

6.1

144

909

A80

ICPC

Trauma/injury NOS

2.8

6.1

130

G44.2

ICD-10 Finland

Tension-type headache

1.4

6.1

301

2233

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

8.6

6.0

H00.00

ICD-10 Finland

Hordeolum

1.8

6.0

511

A04

ICPC

Weakness/tiredness general

1.4

6.0

291

2150

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.6

6.0

155

A03

ICPC

Fever

1.3

6.0

508

4091

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

260

36.41

307.65

3.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1934

9178

4.12

305.80

4.8

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1772

8314

3.77

275.81

4.4

2.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

368

556

7.41

236.75

6.4

1.6

titre

5.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1096

4319

3.42

212.87

5.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1245

5544

3.13

193.39

5.0

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1543

8367

2.74

157.60

2.9

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

134

105

13.31

139.85

13.8

7.9

u/ml

3251.8

23533.3

0.41

(46235355) HIV 1 and 2 tests - Meaningful Use set

1852

11803

2.49

123.78

3.7

2.1

—

(3037121) Protein [Mass/volume] in Urine

258

586

4.72

105.85

4.4

3.0

g/l

0.1

0.4

2.90

187

268

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

136

8.44

84.48

2.3

2.8

31.1

44.9

5.39

(3017143) Hepatitis C virus Ab [Presence] in Serum

980

5400

2.21

82.89

2.9

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

128

192

6.92

81.68

2.2

2.6

42.7

45.5

0.25

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

108

173

6.44

64.67

2.2

3.0

e6/l

951.4

825.1

0.69

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

421

1813

2.54

60.95

2.5

2.7

31.4

31.2

0.16

291

1427

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

407

1827

2.42

53.49

2.4

2.5

u/l

27.7

60.4

0.69

365

1573

(3013762) Body weight Measured

29.39

47.84

1.1

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

802

5014

1.82

42.05

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

240

957

2.64

40.13

1.8

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

433

2253

2.08

38.99

1.9

1.8

—

(3019225) pH of Specimen

297

1346

2.34

37.65

2.9

3.0

—

(3033658) Prothrombin time (PT) actual/Normal

742

4683

1.78

36.96

3.4

3.5

96.5

0.02

726

4551

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

246

4.13

35.89

1.4

—

(42870588) Differential panel, method unspecified - Blood

995

6973

1.64

32.92

6.6

6.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

240

3.97

32.04

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

972

6826

1.63

31.61

2.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1873

15344

1.59

31.35

4.1

3.6

e6/l

23.6

822.2

—

160

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

152

4.69

30.15

2.0

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

264

1249

2.22

30.04

2.5

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1958

16301

1.58

29.74

4.4

3.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

559

3471

1.75

28.57

2.4

1.5

—

(40758558) Short blood count panel - Blood

739

5082

1.60

25.14

6.7

6.5

—

(3029937) Albumin [Presence] in Urine by Test strip

393

6374

0.56

25.14

3.1

estimate

0.0

1.94

117

2530

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

450

2728

1.76

24.72

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

451

2738

1.76

24.64

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

451

2744

1.76

24.44

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

451

2745

1.76

24.41

1.4

—

(3011288) Drugs identified in Urine by Screen method

357

2035

1.86

24.01

3.3

3.4

—

(3019069) Monocytes/100 leukocytes in Blood

1351

10692

1.48

23.59

6.6

6.1

8.0

0.09

1247

10147

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

869

6284

1.54

23.45

1.8

1.6

pmol/l

102.1

98.0

1.76

475

3611

(3006504) Eosinophils/100 leukocytes in Blood

1342

10625

1.48

23.28

6.4

5.9

2.7

0.10

1228

9998

(3009542) Hematocrit [Volume Fraction] of Blood

2712

25031

1.88

22.58

11.6

9.7

40.8

0.02

2368

21419

(3022096) Basophils/100 leukocytes in Blood

1294

10222

1.47

22.42

6.6

6.0

0.7

1.12

1179

9636

(3018010) Neutrophils/100 leukocytes in Blood

1392

11167

1.46

22.18

6.2

5.6

55.0

56.3

4.90

1281

10605

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1146

8854

1.48

22.18

1.9

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

1407

11318

1.46

22.06

6.4

5.7

31.4

30.1

5.52

1292

10719

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2381

21316

1.57

21.28

7.9

7.4

ml/min/173m2

100.5

100.4

0.07

1780

17083

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1222

9641

1.45

20.83

1.9

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

429

2694

1.69

20.51

2.2

2.4

e6/l

5.4

3.9

0.69

179

1366

(40768804) Tissue Pathology biopsy report

1072

8268

1.46

20.50

2.0

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

310

1801

1.80

19.46

9.4

6.0

mmol/l

1.0

4.08

287

1701

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

117

473

2.53

18.98

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

156

3.64

17.41

1.4

1.9

mg/l

15.6

25.7

0.85

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2643

24538

1.65

17.27

9.6

9.1

mg/l

21.4

19.4

2.16

1963

18589

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

447

2965

1.60

17.00

1.4

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1753

15088

1.39

16.69

6.2

u/l

68.7

70.2

1.22

1617

14247

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2584

23935

1.58

16.15

4.7

4.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

427

2843

1.59

15.92

2.1

2.3

e6/l

0.7

1.1

1.50

181

1513

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1155

9330

1.39

15.92

4.9

umol/l

10.1

10.2

0.11

1064

8729

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

229

3.02

15.66

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

325

2.66

15.49

1.1

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1521

12882

1.37

15.46

7.6

8.3

e9/l

3.9

4.0

0.97

1287

11412

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

736

9477

0.70

14.74

2.8

2.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

2384

0.47

14.73

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

444

6248

0.66

14.23

2.5

4.1

—

(1761868) Lipid panel - Serum or Plasma

781

9910

0.71

14.19

1.8

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

380

2.44

13.86

2.1

3.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

227

1329

1.77

13.81

1.5

1.4

—

(3018095) Leukocytes [#/volume] in Urine

913

7230

1.38

13.70

3.4

3.0

e6/l

63.9

65.2

0.02

475

4588

(1001926) Buprenorphine [Presence] in Urine by Screen method

357

2362

1.58

13.57

2.3

2.4

—

(36660697) Celiac disease serology panel - Serum

362

2412

1.57

13.34

1.2

—

(3001604) Monocytes [#/volume] in Blood

1339

11294

1.34

13.16

6.4

5.9

e9/l

0.5

0.87

1168

10059

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

604

4482

1.44

13.15

1.9

1.8

1.5

1.4

3.40

556

4096

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

856

6745

1.38

13.14

4.7

5.0

mmol/l

1.2

7.86

757

6166

(3023511) Choriogonadotropin [Units/volume] in Urine

281

1774

1.64

12.94

1.5

1.4

—

(3016879) Cocaine [Presence] in Urine

406

2798

1.52

12.83

2.5

2.4

—

(3006315) Basophils [#/volume] in Blood

1338

11324

1.33

12.68

6.4

5.9

e9/l

0.0

0.54

1165

10073

(3013115) Eosinophils [#/volume] in Blood

1383

11763

1.33

12.65

6.7

6.2

e9/l

0.2

0.22

1207

10632

(3016650) Hepatitis A virus Ab [Presence] in Serum

107

502

2.17

12.46

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

102

2052

0.48

12.33

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

1392

11882

1.32

12.28

6.3

5.8

e9/l

2.1

2.0

2.25

1232

10786

(3005988) Vibrio sp identified in Specimen by Organism specific culture

234

2.73

12.21

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

234

2.73

12.21

1.3

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

247

1541

1.66

11.91

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

739

1.94

11.86

1.5

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

233

2.70

11.76

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

235

2.67

11.58

1.3

1.5

—

(3025130) Human papilloma virus identified in Specimen

115

579

2.03

11.16

1.8

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

240

2.62

11.12

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

235

2.63

11.05

1.3

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1242

0.38

10.97

2.4

2.8

mmol/l

1.2

0.21

1055

(3007164) IgA [Mass/volume] in Serum or Plasma

748

5912

1.35

10.91

1.5

1.4

g/l

2.2

2.1

1.09

395

3934

(36304419) Bacteria [Presence] in Urine

665

5167

1.37

10.81

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

139

756

1.88

10.79

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

706

5542

1.36

10.75

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

401

2.20

10.64

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

1651

0.46

10.63

2.9

4.4

0.6

0.8

0.27

354

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

142

782

1.86

10.60

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

422

3040

1.45

10.60

2.4

2.3

—

(3025159) Blasts/100 leukocytes in Blood

1539

0.45

10.55

2.6

4.5

0.0

0.4

0.74

292

(3027008) Opiates [Presence] in Urine

421

3036

1.45

10.51

2.4

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

484

2.08

10.43

1.9

2.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1310

11252

1.29

10.41

3.6

3.9

—

(3013512) EKG study

506

3779

1.41

10.40

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

132

715

1.89

10.38

1.3

1.5

—

(40761536) Microorganisms panel - Urine sediment

136

2369

0.55

10.37

3.6

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

1591

0.46

10.27

3.0

4.5

0.0

0.1

6.99

338

(3000764) Benzodiazepines [Presence] in Urine

416

3015

1.44

10.09

2.4

2.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

125

672

1.90

10.07

1.2

1.4

u/l

12.0

14.0

0.45

583

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

634

4967

1.35

9.65

1.9

1.8

mg/l

0.8

0.9

0.47

431

3446

(3000494) Fungus identified in Specimen by Culture

327

2285

1.48

9.57

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.03

9.50

1.1

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1541

0.49

9.17

2.7

4.1

0.5

0.6

0.07

275

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

130

731

1.81

9.12

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

638

5048

1.34

9.02

2.7

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

464

3500

1.39

8.91

1.6

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

282

1940

1.50

8.91

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

301

2101

1.48

8.85

2.3

2.1

nmol/l

12.6

12.0

0.46

263

1909

(3030467) Casts [#/volume] in Urine by Automated count

639

5073

1.33

8.80

2.6

e6/l

0.2

0.3

1.92

408

3705

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

122

681

1.83

8.78

1.5

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

324

2303

1.46

8.68

1.5

1.6

nmol/l

933.8

1159.4

5.07

229

1790

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

130

2.95

8.65

1.1

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

444

3341

1.39

8.64

1.4

nmol/l

20.7

19.9

0.61

379

3013

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

160

2546

0.61

8.62

1.5

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1302

11353

1.26

8.57

3.9

4.0

mmol/l

5.9

6.2

5.43

1136

9969

(3014765) Yersinia sp identified in Stool by Organism specific culture

128

735

1.77

8.40

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2665

25456

1.42

8.31

8.2

7.4

u/l

26.6

27.4

1.07

2553

24738

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

119

671

1.81

8.30

4.3

4.0

mmol/l

24.0

24.1

0.21

113

604

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2347

22005

1.31

8.15

4.5

4.4

mu/l

1.6

1.8

1.98

2173

20992

(3003327) Ova and parasites identified in Stool by Light microscopy

172

1083

1.62

8.04

2.1

1.7

—

(3042936) Bacteria identified in Isolate by Culture

346

2529

1.42

7.96

1.7

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

281

1988

1.46

7.71

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

398

0.22

7.57

2.2

4.0

mmol/l

1.1

1.4

—

392

(3024561) Albumin [Mass/volume] in Serum or Plasma

838

7016

1.27

7.55

3.9

4.5

g/l

38.4

37.6

5.09

775

6558

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.49

7.54

3.8

3.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1752

15931

1.24

7.50

3.3

3.4

mm/h

7.6

7.8

0.33

1590

14991

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

242

1677

1.48

7.39

2.3

2.2

au/ml

21.9

20.5

0.09

151

(3024891) Influenza virus A+B Ag [Presence] in Specimen

135

819

1.68

7.32

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

108

616

1.78

7.29

1.5

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

1022

1.60

7.09

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

605

7334

0.78

6.72

2.6

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1970

18253

1.23

6.60

3.1

2.7

u/l

34.1

0.00

1863

17582

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

266

1923

1.42

6.51

1.3

miu/ml

215.5

234.8

0.34

113

967

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

1571

1.46

6.45

1.3

1.2

au/ml

23.1

37.7

0.98

(3027944) Amphetamines [Presence] in Urine

388

2988

1.34

6.45

2.4

2.3

—

(3023368) Bacteria identified in Blood by Culture

483

3844

1.31

6.37

3.3

3.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

340

0.23

6.35

2.3

4.2

mmol/l

3.7

3.8

—

317

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

171

1143

1.53

6.24

1.7

nmol/l

41.7

38.9

0.58

163

1127

(3048929) Epstein Barr virus Ab [Presence] in Serum

221

1560

1.45

6.16

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

223

1578

1.45

6.14

1.8

2.1

e9/l

4.2

0.04

153

1373

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

890

7670

1.23

5.94

4.3

3.0

u/l

28.7

29.7

0.60

845

7285

(3002582) Erythrocytes [#/volume] in Urine

670

5601

1.25

5.91

2.7

2.6

e6/l

55.2

99.8

0.64

436

4159

(3002523) Influenza virus A Ag [Presence] in Specimen

121

758

1.62

5.86

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

121

759

1.62

5.83

1.1

—

(3023410) Appearance of Cerebral spinal fluid

272

2.04

5.78

1.8

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

502

4066

1.28

5.76

2.6

ug/g

117.8

106.5

0.22

385

3226

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.47

5.73

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

301

2272

1.36

5.70

1.4

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

558

4584

1.27

5.70

1.5

mmol/l

1.4

0.17

517

4079

(3044290) Cell count panel - Cerebral spinal fluid

556

1.71

5.67

1.6

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

235

2.10

5.59

1.6

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2336

22177

1.24

5.58

8.4

8.3

mmol/l

139.4

139.5

0.82

2234

21474

(3023103) Potassium [Moles/volume] in Serum or Plasma

2343

22255

1.24

5.55

8.5

8.4

mmol/l

3.9

3.06

2227

21480

(3002256) Pathology report gross observation

318

2432

1.34

5.54

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

292

2217

1.35

5.34

1.4

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

327

2532

1.33

5.24

1.4

1.6

—

(3020891) Body temperature

468

0.32

5.23

2.1

4.1

—

(3009508) Creatinine [Moles/volume] in Urine

599

5010

1.24

5.20

3.1

3.5

mmol/l

8.9

0.05

511

4410

(3005033) Fetal Nuchal fold Thickness US

290

2211

1.35

5.16

1.4

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

641

5414

1.23

5.08

2.6

mmol/l

2.3

0.93

510

4935

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

128

2.44

5.04

2.1

3.4

umol/l

145.2

159.4

0.10

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

341

2676

1.31

4.97

2.7

2.6

ng/l

284.0

486.1

0.65

158

1263

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

117

2.49

4.95

2.1

2.2

—

(3038026) Centromere Ab [Units/volume] in Serum

136

2.37

4.90

1.3

—

32.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

188

2.14

4.85

2.9

2.8

e6/l

773.5

518.0

2.15

151

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

2.35

4.82

3.3

2.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

456

3730

1.26

4.79

1.3

u/ml

6.9

8.5

0.24

139

1629

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

187

1346

1.42

4.75

2.3

2.5

g/l

0.2

0.20

168

1253

(3045462) Protein/Creatinine [Ratio] in Urine

3.95

4.71

1.5

2.6

g/mol

14.9

42.9

0.98

(3016018) Differential panel - Cerebral spinal fluid

280

1.91

4.69

1.9

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.85

4.65

1.1

98.9

93.1

0.42

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.85

4.65

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

588

1.62

4.65

1.2

1.3

u/ml

18.1

16.2

0.06

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

423

1.72

4.53

1.2

1.3

—

7.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

1454

1.39

4.49

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

195

1429

1.39

4.48

1.5

1.7

mg/l

3.3

4.0

0.88

145

933

(3037522) Nuclear Ab [Titer] in Serum

419

3423

1.26

4.45

1.4

titre

513.2

529.3

0.07

605

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.01

4.43

1.5

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

611

0.45

4.41

2.0

1.8

13.2

13.0

0.39

603

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

183

2.09

4.36

2.1

1.8

iu/ml

2317183.1

2299802.9

—

(40768443) Skin Pathology biopsy report

112

744

1.53

4.30

1.2

1.1

—

(3019060) Gas panel - Arterial blood

696

0.50

4.25

2.6

5.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

145

1019

1.44

4.23

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

801

7024

1.19

4.22

1.4

1.3

u/ml

2.5

1.6

0.54

148

2051

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

863

7618

1.19

4.22

5.5

5.4

mmol/l

1.2

7.06

761

6380

(3026008) Bacteria identified in Urine by Culture

638

5480

1.21

4.21

2.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

580

1.59

4.20

1.3

mmol/l

3.5

3.6

0.62

537

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

305

2416

1.29

4.16

2.6

2.4

mmol/l

2.4

0.16

254

2087

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

278

2179

1.30

4.11

2.9

2.6

umol/l

6.3

6.1

0.07

234

1825

(3008037) Lactate [Moles/volume] in Venous blood

215

0.23

4.10

4.0

2.5

mmol/l

1.4

—

207

(3030905) Polymorphonuclear cells [#/volume] in Blood

482

0.41

4.08

5.1

3.5

e9/l

5.4

3.9

1.33

482

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.20

4.05

1.1

2.5

—

(3021788) Differential panel - Synovial fluid

231

1.92

4.01

1.5

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

455

1.64

3.97

1.3

1.5

—

4.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

518

0.44

3.97

2.6

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.48

3.96

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

2889

28398

1.49

3.95

14.7

13.5

e9/l

259.7

261.2

0.70

2797

27833

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

487

0.43

3.91

5.4

3.7

61.7

56.0

1.18

487

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

583

1.56

3.90

1.2

1.3

u/ml

2.6

4.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

457

0.41

3.87

3.4

6.0

1.0

0.9

0.46

420

(3022313) Gas panel - Capillary blood

530

1.58

3.83

3.0

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

214

1.93

3.82

1.5

1.6

—

(4034850)

640

0.51

3.75

5.6

6.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

509

4324

1.21

3.74

2.1

umol/l

1671.2

2823.8

0.55

458

3956

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

310

1.76

3.74

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

310

1.76

3.74

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

2893

28465

1.48

3.71

14.7

13.5

e9/l

6.9

6.8

1.36

2797

27857

(3035941) MCH [Entitic mass]

2891

28444

1.47

3.68

14.6

13.4

30.2

29.9

12.89

2844

28173

(3000963) Hemoglobin [Mass/volume] in Blood

2893

28468

1.47

3.68

14.7

13.5

g/l

137.1

137.6

0.96

2847

28188

(3024731) MCV [Entitic volume]

2891

28446

1.47

3.66

14.6

13.4

89.9

89.2

14.61

2844

28177

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

183

1.98

3.63

2.9

2.8

e9/l

0.3

0.2

0.76

151

(3026361) Erythrocytes [#/volume] in Blood

2891

28450

1.46

3.61

14.7

13.4

e12/l

4.6

11.34

2799

27869

(3049717) Cytology report of Urine Cyto stain

233

1.86

3.60

1.5

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1.87

3.59

1.4

g/l

40.3

39.5

0.41

206

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

233

0.30

3.58

1.4

1.6

mmol/l

5.1

—

223

(3038515) Glucose [Moles/volume] in Venous blood

196

0.25

3.52

4.0

2.6

mmol/l

6.4

6.9

—

191

(3044009) aPTT.lupus sensitive (LA screen)

3.34

3.47

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

956

8622

1.16

3.46

2.2

nmol/l

72.1

69.9

1.64

870

8145

(3022145) Colonoscopy Study observation

260

2069

1.28

3.45

1.3

1.4

—

(4198724)

303

1.73

3.45

1.8

3.7

—

(3003694) ABO and Rh group [Type] in Blood

1079

9822

1.15

3.44

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

274

1.76

3.42

1.5

1.7

e6/l

7487.7

12796.1

0.73

196

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.99

3.41

1.1

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.99

3.41

1.1

2.5

—

(44806071)

3.10

3.37

1.0

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

469

1.57

3.33

2.2

2.5

ug/l

459.9

325.6

0.26

421

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

383

1.63

3.32

1.2

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

567

1.51

3.29

2.0

2.1

g/l

1.1

1.3

0.64

506

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

519

1.54

3.28

1.1

au/ml

28.1

12.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

624

5463

1.18

3.27

2.0

2.3

ng/l

24.9

29.2

0.16

184

2041

(3000570) Elastase.pancreatic [Mass/mass] in Stool

440

1.58

3.26

1.3

ug/g

242.0

326.5

1.81

205

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

488

0.49

3.20

3.4

3.2

56.6

52.7

0.34

483

(3025941) Bacteria identified in Stool by Culture

217

1705

1.29

3.20

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

151

1129

1.36

3.15

1.6

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

335

1.65

3.13

1.1

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

457

0.48

3.12

3.4

5.9

1.8

1.9

0.02

419

(3005011) Chlamydia sp Ab [Titer] in Serum

3.09

1.6

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

467

4007

1.20

3.08

1.3

iu/ml

27.2

19.1

1.01

111

1161

(3019174) dRVVT (LA screen)

3.24

3.05

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

440

1.56

3.04

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

562

1.49

3.02

1.7

2.4

mg/l

11.4

9.5

2.49

533

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

570

4988

1.18

2.99

2.0

mg/l

2.5

2.6

0.74

438

4295

(3011412) CD3 cells [#/volume] in Blood

226

1.78

2.98

2.7

e9/l

1.1

1.3

0.43

123

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.55

2.95

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

226

1806

1.27

2.93

2.5

4.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

250

1.73

2.92

1.4

g/l

0.0

0.5

2.48

234

(3021901) Oxygen saturation in Capillary blood

209

0.33

2.92

1.9

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

510

4432

1.18

2.91

1.9

2.0

u/l

218.3

251.9

0.30

480

4210

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

321

0.40

2.90

30.2

20.9

nmol/l

945.5

1409.6

1.44

308

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

502

1.51

2.89

1.4

1.2

u/ml

4.2

4.4

0.04

231

(3029612) Listeria sp Ab [Titer] in Serum

5.39

2.87

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

123

2.04

2.81

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

302

0.39

2.81

1.5

2.0

18.5

17.6

—

133

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

316

0.41

2.81

21.3

14.6

nmol/l

587.2

801.7

1.00

304

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

261

1.70

2.80

1.1

1.2

—

(4146454)

2.23

2.80

3.0

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

187

1.83

2.78

1.1

1.2

u/ml

1.8

4.9

—

(3001556) Androgen free Index in Serum or Plasma

2.17

2.76

1.1

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

341

0.44

2.75

1.4

2.1

g/l

134.1

134.9

—

254

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.86

2.75

1.5

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

297

0.40

2.71

1.1

1.4

—

(3008898) HLA-B27 [Presence]

181

1422

1.29

2.71

1.1

—

(40761511) CBC panel - Blood by Automated count

2685

26276

1.21

2.62

8.7

8.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.90

2.58

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

2.57

0.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

143

1099

1.32

2.54

2.2

2.3

umol/l

4.7

4.8

0.07

830

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.23

2.53

1.2

1.1

—

(3000991) Gas panel - Venous blood

141

1084

1.32

2.50

9.2

8.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

462

1.48

2.49

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.47

2.48

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.83

2.47

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

471

1.48

2.47

1.1

116.7

114.0

0.26

427

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

310

1.59

2.47

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

151

1.86

2.47

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

284

0.42

2.46

5.2

2.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2157

20792

1.13

2.46

3.2

2.9

mmol/l

5.5

5.6

1.44

1958

19591

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1989

19078

1.13

2.46

3.8

3.9

pmol/l

14.2

14.3

0.99

1795

17799

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

310

0.45

2.43

1.5

2.7

ug/min

163.1

122.4

—

213

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

581

0.60

2.43

1.2

1.6

mmol/l

6.5

0.03

412

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

406

3516

1.18

2.42

2.5

2.4

u/l

4925.6

6865.2

0.84

181

1466

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

108

803

1.36

2.41

2.8

2.3

97.5

94.3

0.75

101

724

(3045716) Anion gap in Serum or Plasma

0.00

2.40

0.0

2.3

—

9.2

—

(3002032) Base excess in Venous blood by calculation

146

1135

1.30

2.40

4.0

3.8

mmol/l

0.9

1.7

1.83

121

917

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

549

1.43

2.39

2.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

2.39

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

492

1.45

2.37

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

2.03

2.36

2.3

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

526

1.44

2.35

3.3

mg/l

1.2

0.19

496

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

338

1.55

2.35

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1.61

2.34

1.4

g/l

10.3

10.6

0.24

245

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

363

1.52

2.33

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

869

1.34

2.32

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.05

2.31

1.3

1.4

e6/l

23715.8

42567.2

0.36

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

1.89

2.31

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

177

1.76

2.30

1.2

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

340

1.54

2.30

1.2

1.1

89.2

93.1

0.41

318

(3024354) Oxygen [Partial pressure] in Venous blood

122

933

1.32

2.27

3.5

2.9

kpa

5.2

4.9

0.75

111

905

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1.58

2.25

1.4

g/l

3.0

3.1

0.04

231

(3021447) Carbon dioxide [Partial pressure] in Venous blood

146

1148

1.29

2.22

4.0

3.7

kpa

5.8

5.9

0.52

137

1117

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

429

0.56

2.22

1.6

mmol/l

11.3

11.5

—

(3049242) von Willebrand panel - Platelet poor plasma

5.56

2.21

2.4

1.2

—

(3003396) Base excess in Arterial blood by calculation

1301

0.74

2.19

9.7

8.4

mmol/l

-0.5

0.7

1.81

953

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

328

1.53

2.19

1.1

1.2

mg/l

29.6

38.2

1.73

257

(1616796) Gas panel - Central venous blood

388

0.54

2.18

2.1

2.6

—

(4024509)

151

1.80

2.16

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

277

2347

1.20

2.14

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

314

1.54

2.14

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

1.70

2.13

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

100

751

1.34

2.13

3.1

2.7

151.2

162.9

1.08

714

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

145

1.80

2.10

1.5

1.7

44.8

49.9

0.31

(3032057) Clostridioides difficile [Presence] in Stool

3.21

2.09

2.5

1.9

—

(1002224) Polysomnography panel

160

1284

1.26

2.08

1.1

—

(3036489) Thrombin time

117

902

1.31

2.08

2.7

2.2

20.5

20.9

0.62

750

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

506

1.41

2.08

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

1.86

2.06

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

120

930

1.30

2.06

1.9

2.2

u/l

42.7

39.2

1.33

111

871

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.51

2.05

10.0

6.5

mmol/l

7.9

6.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

2.05

0.0

3.1

—

(3044889) 12 lead EKG panel

1197

12715

0.90

2.04

2.3

2.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

783

1.33

2.03

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

281

2397

1.19

2.03

1.5

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

192

1.67

2.03

1.1

—

(3000330) Specific gravity of Urine by Test strip

756

0.68

2.03

2.8

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1.61

2.02

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1915

18422

1.11

2.02

3.7

3.5

mmol/mol

35.5

36.8

10.71

1796

17583

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.23

2.00

1.1

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.23

2.00

1.0

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

288

3348

0.85

1.99

1.4

1.5

pmol/l

414.8

33176253.6

2.98

241

2963

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

197

1627

1.23

1.99

2.3

2.0

ug/l

0.6

0.10

110

688

(21494755) Public health laboratory ask at order entry panel

417

4705

0.87

1.96

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

233

1.60

1.96

1.2

1.4

74.6

74.0

0.13

218

(3020630) Protein [Mass/volume] in Serum or Plasma

100

762

1.32

1.95

1.8

g/l

68.5

68.3

0.11

720

(3051611) Lipemic interference index of Serum or Plasma

134

1.80

1.95

2.4

3.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.19

1.94

1.1

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.19

1.94

1.1

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.19

1.94

1.1

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.19

1.94

1.1

2.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.57

1.92

1.1

1.3

—

(4306422)

506

1.39

1.91

1.2

—

(3044927) Protein electrophoresis panel - Urine

2.25

1.90

1.2

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

448

3986

1.15

1.90

2.2

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

263

2245

1.19

1.90

1.5

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.31

1.87

1.1

1.8

u/l

11.8

13.0

0.22

(3035947) Staphylolysin Ab [Units/volume] in Serum

100

1.91

1.85

1.2

1.1

—

4.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

301

1.50

1.85

1.4

1.3

g/l

7.1

0.10

236

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

301

1.50

1.85

1.4

1.3

g/l

3.7

3.9

0.51

218

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

301

1.50

1.85

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.21

1.84

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.21

1.84

1.2

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.53

1.83

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.53

1.83

2.0

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.83

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

198

1.62

1.83

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

108

1.86

1.81

2.3

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

137

1694

0.80

1.81

2.9

2.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1394

13244

1.10

1.81

3.0

2.9

ug/l

73.1

70.0

0.38

1296

12583

(3013290) Carbon dioxide [Partial pressure] in Blood

390

0.59

1.81

2.0

2.8

kpa

4.9

0.06

385

(3012501) Base excess in Blood by calculation

390

0.59

1.81

2.0

2.8

mmol/l

2.3

2.0

—

214

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

199

1.61

1.80

1.3

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

389

0.59

1.79

2.0

2.8

kpa

9.0

9.5

0.98

384

(40761535) Cells panel - Urine sediment

101

1292

0.77

1.78

2.9

3.0

—

(3021589) Normoblasts [#/volume] in Blood

964

10293

0.91

1.76

8.0

7.7

e9/l

0.0

0.78

735

8541

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

224

1.57

1.76

5.9

6.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

224

1.57

1.76

2.9

3.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

1.74

1.2

1.1

—

(4035726)

141

1144

1.24

1.72

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

101

787

1.29

1.71

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

583

5312

1.12

1.70

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

226

1.56

1.70

1.3

1.4

mu/l

455.3

435.1

0.08

211

(3024928) Oxygen saturation in Venous blood

291

1.48

1.69

2.5

2.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

181

1.61

1.63

1.1

iu/ml

11.5

5.3

—

(3019150) Specific gravity of Urine by Refractometry

468

5175

0.89

1.63

2.9

3.1

kg/l

1.0

0.87

744

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

768

0.72

1.62

1.5

1.8

ug/l

12.7

7.4

0.46

675

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.33

1.60

2.5

2.9

—

(4211845)

121

1.74

1.58

2.4

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

586

1.32

1.57

1.6

1.5

e6/l

33.1

20.7

0.39

453

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.58

1.57

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

207

1.55

1.56

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

129

1.71

1.56

1.1

—

(4010399)

142

1168

1.23

1.55

1.4

—

(3010421) pH of Blood

445

0.65

1.54

1.9

2.8

7.4

0.28

385

(3018572) Chloride [Moles/volume] in Blood

272

0.55

1.54

3.6

8.2

mmol/l

105.1

105.6

0.14

240

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.57

1.54

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.57

1.54

1.1

—

(3039000) Anion gap in Blood

271

0.55

1.52

3.6

8.2

mmol/l

11.9

11.7

0.10

239

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.56

1.51

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

1.49

0.0

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

1.49

0.0

3.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

218

1.52

1.48

1.0

1.1

u/l

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

771

1.27

1.45

1.8

1.9

g/l

1.1

1.2

0.91

729

(3004588) Protein electrophoresis panel - Serum or Plasma

559

1.31

1.45

1.3

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

797

0.75

1.44

1.4

1.6

mmol/l

7.2

7.5

0.38

483

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

586

1.30

1.44

1.6

1.5

e6/l

134.0

7363.7

0.61

479

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.13

1.44

1.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.92

1.43

1.1

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

347

1.39

1.38

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

305

3424

0.88

1.37

4.0

4.4

mg/mmol

12.8

13.9

0.09

203

2415

(3036481) Cortisol [Moles/volume] in Serum or Plasma

252

2211

1.15

1.35

1.8

2.0

nmol/l

399.1

380.2

0.75

221

2033

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

752

1.26

1.35

1.9

g/l

0.2

0.22

709

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

720

0.75

1.35

15.2

10.5

1.5

0.00

714

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

183

1.54

1.34

1.6

2.2

13.3

0.01

111

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.87

1.34

1.1

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.15

1.33

1.0

1.4

nmol/l

0.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

0.00

1.32

0.0

1.1

—

0.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

416

0.67

1.31

2.3

2.8

mg/l

20.3

23.1

—

253

(4268621)

368

1.36

1.31

2.4

2.2

—

(3017569) Oxygen content in Arterial blood

0.00

1.31

0.0

3.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

1.30

1.0

2.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.89

1.28

1.8

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.72

1.27

4.8

4.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

269

1.42

1.25

4.7

4.2

u/ml

0.4

0.3

0.25

131

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

435

0.69

1.25

1.1

iu/ml

513.5

3014.2

—

132

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

375

0.66

1.24

1.5

2.1

ug/l

1.2

1.4

0.09

334

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

253

1.43

1.24

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

187

1.50

1.23

1.6

2.2

73.5

75.5

0.33

179

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

100

1.70

1.23

2.1

2.2

umol/l

11.6

13.6

0.56

100

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.63

1.21

1.0

1.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.63

1.21

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

263

1.41

1.20

1.4

1.3

pmol/l

72.6

64.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1.53

1.20

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

687

6426

1.09

1.20

1.7

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

644

6008

1.09

1.19

2.3

2.4

u/l

54.8

55.3

0.11

573

5581

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

105

865

1.22

1.19

4.4

4.1

ng/l

71.4

74.6

0.15

793

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

1.67

1.16

1.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

1.67

1.16

1.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

1.67

1.16

1.2

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

257

1.41

1.15

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.05

1.15

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.05

1.15

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.50

1.15

4.2

4.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

1.14

0.0

4.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

973

1.20

1.11

1.0

1.1

u/ml

2.1

3.3

0.49

166

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

110

918

1.21

1.11

1.7

1.6

iu/ml

0.0

0.2

1.00

167

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.38

1.09

1.4

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

549

1.26

1.09

1.0

1.1

u/ml

1.7

2.6

1.07

322

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

231

0.60

1.08

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

227

1.41

1.07

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

202

1.44

1.07

1.8

—

(44790048)

204

0.59

1.05

1.5

—

(44790049)

204

0.59

1.05

1.5

—

(44790047)

204

0.59

1.05

1.5

—

(44806118)

204

0.59

1.05

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.79

1.04

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

536

1.26

1.02

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

299

3291

0.90

1.01

3.3

3.6

mg/l

304.9

393.2

0.15

190

2299

(3007566) Smooth muscle Ab [Titer] in Serum

664

1.23

1.00

1.3

1.4

titre

57.5

78.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.18

0.98

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

275

1.35

0.97

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

649

1.22

0.97

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

124

1.54

0.96

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

282

0.67

0.95

1.2

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

193

1713

1.14

0.94

2.0

2.3

g/l

10.6

0.01

175

1561

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

133

1.51

0.94

1.6

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

190

1685

1.14

0.94

1.3

1.4

u/l

8.4

7.8

0.33

158

1395

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

295

1.33

0.92

2.3

2.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

709

1.20

0.91

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

402

1.27

0.90

1.4

1.7

g/l

0.6

0.7

0.35

299

(3051651) Icteric interference index of Serum or Plasma

102

1.57

0.90

1.6

3.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

729

0.81

0.89

2.9

2.8

g/l

130.7

136.4

1.13

711

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

484

0.76

0.89

1.4

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

128

0.55

0.88

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

758

1.19

0.88

2.8

2.5

mmol/l

0.5

1.1

0.94

525

(3045424) Erythrocytes [Presence] in Urine

343

1.29

0.86

1.3

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

153

1349

1.14

0.85

2.1

2.8

1.6

0.37

131

1201

(3036603) Volume of Urine

112

1.52

0.84

1.4

1.6

—

2285.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

670

1.20

0.84

1.4

u/ml

107.3

101.8

0.14

138

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.76

0.83

1.3

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

137

0.58

0.83

1.0

2.7

ug/l

26.5

336.7

—

125

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

721

0.81

0.82

1.6

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

296

0.71

0.82

1.9

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

163

1.41

0.82

1.5

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.88

0.81

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.88

0.81

1.8

2.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

130

1137

1.15

0.81

1.1

—

3.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.55

0.81

1.2

1.5

nmol/l

135.6

137.9

0.06

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1.36

0.81

1.7

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.70

0.80

6.0

5.5

—

(3000492) Spirometry study

290

2665

1.10

0.79

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.1

—

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.79

0.0

8.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

139

1.44

0.79

1.5

1.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.82

0.79

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.78

0.0

2.5

—

0.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.52

0.78

1.2

2.0

—

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

1.48

0.76

1.1

1.2

g/l

0.3

0.78

(3032080) INR in Blood by Coagulation assay

589

5580

1.07

0.76

3.6

4.7

inr

1.1

0.04

100

2091

(3035933) Granulocytes/100 leukocytes in Blood

107

1.50

0.76

1.1

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

233

2124

1.11

0.76

1.3

1.4

iu/l

17.2

15.1

0.52

182

1780

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.70

0.75

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

288

1.29

0.75

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

606

1.19

0.74

1.4

1.8

—

378.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

254

1.30

0.73

4.1

3.1

—

(40768793) Breast Pathology biopsy report

415

1.23

0.73

1.4

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

322

0.74

0.72

5.5

4.0

u/ml

14.2

134.2

2.04

271

(3042631) Mycobacterium sp identified in Specimen

110

0.54

0.72

2.5

3.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.58

0.71

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

169

1.36

0.69

1.5

1.2

—

(3044941) Cell count panel - Synovial fluid

204

1.33

0.69

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

1.64

0.68

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.53

0.68

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.60

0.68

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

401

1.23

0.68

5.9

5.7

umol/l

317.4

377.0

2.07

343

(3000060) B lymphocytes [#/volume] in Blood

1.49

0.66

1.2

2.1

e6/l

232.0

160.6

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.49

0.66

1.1

1.3

u/l

175.2

190.6

0.81

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

191

0.68

0.66

1.2

u/ml

0.2

0.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

178

1618

1.11

0.64

3.5

4.0

u/l

221.0

229.2

0.36

162

1535

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.2

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.73

0.64

1.8

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.73

0.64

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.67

0.61

1.0

ng/l

1124.0

870.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.0

ng/l

20.2

31.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.60

0.0

1.1

—

5.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

16.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

254

1.26

0.59

1.3

1.6

promille

1.4

0.06

193

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.59

0.0

5.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

744

1.15

0.58

1.2

1.7

—

9.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

114

0.61

0.58

48.3

33.4

ug/l

8.1

7.5

—

106

(44813793)

229

0.74

0.55

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.54

0.55

1.0

1.2

—

(4027681)

275

1.24

0.55

1.1

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

1.54

0.53

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.43

0.53

1.5

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

723

1.14

0.52

1.1

u/ml

7.7

6.4

0.20

321

(21494890) Protein electrophoresis panel - 24 hour Urine

1.43

0.52

1.1

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

686

1.14

0.51

1.9

2.7

ng/l

117.0

82.5

0.43

571

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

639

1.15

0.51

1.1

u/ml

0.1

0.4

0.95

141

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.45

0.51

1.8

1.5

u/l

0.6

3.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

170

1.30

0.51

1.5

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

197

1.27

0.51

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.50

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

291

0.79

0.50

1.5

1.8

—

(3017509) Phencyclidine [Presence] in Urine

1.49

0.49

1.2

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

140

1280

1.10

0.49

1.9

1.8

g/l

1.3

0.08

125

1193

(3018677) aPTT in Platelet poor plasma by Coagulation assay

247

2314

1.07

0.48

2.4

2.3

29.0

29.3

0.69

240

2224

(3014148) Varicella zoster virus Ab [Titer] in Serum

635

1.14

0.47

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.47

0.47

1.1

1.2

u/l

8.5

31.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

236

1.23

0.46

1.4

1.7

—

(40768795) Lymph node Pathology biopsy report

138

1.31

0.45

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

371

3533

1.06

0.45

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

228

1.23

0.45

1.1

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

122

1114

1.10

0.45

1.7

2.1

u/ml

30.3

30.7

0.01

117

1082

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

516

1.15

0.44

1.4

1.2

u/ml

3.3

3.6

0.09

180

(3012095) Magnesium [Moles/volume] in Serum or Plasma

254

2393

1.07

0.44

4.3

3.4

mmol/l

0.8

0.42

238

2250

(3012441) Differential panel - Pleural fluid

1.37

0.44

1.4

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.37

0.44

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

284

1.20

0.43

1.1

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

111

1217

0.91

0.43

9.5

8.9

inr

1.0

1.1

0.96

236

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

174

0.75

0.43

1.4

—

(3023419) Bacteria identified in Sputum by Culture

130

0.69

0.43

1.3

3.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.42

1.3

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.56

0.42

1.0

ng/l

188.4

213.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.38

0.42

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.38

0.42

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.38

0.42

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

0.64

0.42

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

784

1.11

0.42

1.1

u/ml

3.9

4.8

0.20

328

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

131

1.30

0.42

1.1

1.2

u/l

51.7

55.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.43

0.41

1.1

1.2

u/l

78.2

101.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

150

0.73

0.41

2.6

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

351

1.17

0.41

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

27.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.41

0.0

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

161

0.74

0.41

1.1

1.4

—

72.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

422

0.85

0.40

1.3

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.37

0.40

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2112

21342

0.96

0.39

2.9

2.7

mmol/l

1.2

0.43

1975

20464

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.39

0.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.39

0.0

6.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.39

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

1.32

0.39

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

196

1.23

0.39

1.1

1.2

u/l

10.3

30.4

0.95

172

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

149

1601

0.93

0.38

1.8

2.1

—

(3018418) pH of Serum or Plasma

468

4507

1.05

0.38

3.4

3.5

7.4

0.72

917

(46235168) Fasting glucose [Moles/volume] in Blood

1.39

0.38

1.2

—

6.2

—

(40768446) Kidney Pathology biopsy report

1.33

0.37

1.8

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

113

0.71

0.37

1.0

1.4

nmol/l

6.1

6.3

—

108

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.35

0.37

2.8

1.7

nmol/l

1360005.6

603232.4

—

(3023520) Reticulocytes [#/volume] in Blood

869

1.10

0.36

2.5

2.6

e9/l

61.3

72.5

1.84

611

(3026782) Osmolality of Urine

375

3599

1.05

0.36

2.5

2.3

mosm/kgh2o

592.3

556.8

1.91

308

3072

(3045788) Cell count panel - Pleural fluid

1.43

0.35

1.5

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

262

2495

1.05

0.34

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

181

1.22

0.34

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

563

0.89

0.34

2.6

0.6

0.7

0.30

540

(3002619) Bacteria identified in Specimen by Culture

1.33

0.33

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2209

22278

0.97

0.33

3.2

2.9

mmol/l

1.4

0.20

2069

21348

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

144

0.76

0.33

1.5

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

294

1.16

0.32

1.1

1.0

u/ml

0.3

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.32

3.6

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

790

1.09

0.31

2.0

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

101

1.29

0.31

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

0.81

0.31

1.3

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1047

0.92

0.30

1.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

142

0.77

0.30

3.4

4.9

u/ml

1623.1

214.7

0.54

132

(3042733) HLA Ab [Presence] in Serum

1.31

0.30

5.1

4.5

—

(3042517) Benzodiazepines panel - Urine

1.31

0.30

1.0

2.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

111

1.26

0.30

1.0

1.1

—

(3022621) pH of Urine by Test strip

126

1344

0.93

0.29

2.3

2.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

619

0.90

0.29

13.4

11.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.23

0.29

1.0

1.1

—

(3024263) Appearance of Synovial fluid

1.23

0.29

1.4

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.23

0.29

1.0

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.23

0.29

1.0

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

270

0.85

0.28

4.3

4.0

u/ml

510.2

73.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

237

2475

0.95

0.28

2.5

2.1

g/l

2.4

2.5

0.97

215

2274

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.27

0.27

2.9

3.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

177

1.19

0.27

2.8

3.1

mg/l

9.1

8.6

0.10

142

(3037756) Immunofixation for Serum or Plasma

118

0.76

0.27

1.1

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

139

0.79

0.27

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

197

1.17

0.25

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

170

1.18

0.24

1.5

2.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.27

0.24

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

1.17

0.24

1.1

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

166

1583

1.05

0.24

7.8

7.2

mmol/l

105.2

104.8

0.59

166

1550

(3003888) Timothy IgE Ab [Units/volume] in Serum

931

1.07

0.23

1.1

u/ml

6.0

7.4

0.35

537

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

200

0.85

0.22

1.0

1.1

miu/ml

942.6

1547.5

3.68

200

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.76

0.22

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

146

0.82

0.22

2.2

1.4

nmol/l

0.6

1.4

3.19

133

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.22

0.22

1.2

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

377

3873

0.97

0.21

2.3

2.2

e6/l

10.7

8.3

0.45

316

3371

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

2.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

2.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.6

—

19.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

514.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

7.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

7.5

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

3.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

119

1251

0.95

0.20

1.8

2.0

ml/min/173m2

92.1

86.0

0.85

451

(3024932) HLA-DR beta [Type]

1.25

0.20

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

751

1.07

0.20

1.3

1.2

u/ml

236.0

230.0

0.08

498

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

221

1.13

0.20

1.2

1.1

ratio

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1169

11828

0.98

0.20

2.9

estimate

0.0

0.44

113

2492

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.20

0.19

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.18

0.19

2.7

2.1

—

163.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

598

1.07

0.19

1.4

pmol/l

45.0

51.4

1.04

579

(3024471) HLA-A [Type]

1.24

0.18

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

158

1519

1.04

0.18

1.4

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

237

0.89

0.17

2.0

1.8

—

(3003338) MCHC [Mass/volume]

2325

23356

0.98

0.17

12.2

11.1

g/l

334.6

334.3

0.99

2307

23156

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.13

0.17

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

215

2218

0.97

0.17

2.7

2.2

26.1

24.9

0.64

198

1914

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

205

0.88

0.17

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

148

1.15

0.17

3.5

2.6

nmol/l

3.2

40.7

0.48

139

(3010375) cycloSPORINE [Mass/volume] in Blood

0.79

0.15

37.5

25.2

ug/l

135.0

113.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

790

0.95

0.15

3.9

4.2

ug/l

14.8

65.7

0.52

544

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.11

0.15

1.0

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.08

0.14

1.0

1.1

100.3

103.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

217

1.11

0.14

1.1

1.6

—

(3045142) Bone marrow Pathology biopsy report

112

1.16

0.14

1.1

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

269

2754

0.97

0.14

2.4

2.2

umol/l

15.3

15.1

0.11

251

2543

(44816559) Phosphatidylethanol [Mass/volume] in Blood

743

1.05

0.14

1.5

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

118

0.85

0.14

1.1

1.2

91.8

115.7

—

107

(3035320) C reactive protein [Mass/volume] in Body fluid

170

0.88

0.13

1.9

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

882

1.04

0.13

1.1

u/ml

0.6

1.4

2.21

397

(3021387) Prolactin [Units/volume] in Serum or Plasma

248

2423

1.03

0.13

1.6

mu/l

289.5

293.6

0.06

217

2160

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

127

0.87

0.12

8.0

7.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

375

0.93

0.12

1.3

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

107

1033

1.04

0.12

1.1

u/ml

2.3

1.5

0.28

443

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

133

1291

1.03

0.11

1.2

ug/l

3.1

3.7

0.84

128

1228

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

357

1.07

0.11

5.1

2.8

nmol/l

0.7

0.9

0.89

320

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

225

2204

1.02

0.10

2.6

2.5

20.3

21.7

0.44

549

(3032773) Endomysium IgG Ab [Titer] in Serum

270

0.93

0.10

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

261

2562

1.02

0.10

1.2

iu/ml

145.8

148.3

0.03

1007

(3021601) Nitrite [Presence] in Urine by Test strip

1175

11829

0.99

0.10

4.7

4.0

estimate

0.0

0.80

118

2595

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

371

0.94

0.09

1.3

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.06

0.09

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.06

0.09

1.0

1.9

u/l

7.9

15.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

145

1.10

0.09

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

921

1.03

0.09

1.1

u/ml

4.0

2.4

0.36

246

(3015183) Erythrocyte sedimentation rate

223

1.08

0.09

1.4

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

124

0.89

0.09

1.5

nmol/l

3.1

3.5

—

(4038314)

1.03

0.08

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

291

2869

1.02

0.08

3.1

2.6

ug/l

1.6

1.3

0.82

261

2650

(3036782) Glucose [Moles/volume] in Pleural fluid

0.77

0.08

1.2

1.1

mmol/l

2.5

6.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.08

0.08

1.4

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

915

0.97

0.07

1.5

nmol/l

0.3

0.5

3.71

776

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

126

1232

1.02

0.07

1.6

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.07

0.07

1.6

1.9

—

45506.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

884

0.97

0.07

10.2

7.1

mmol/l

24.2

24.3

0.11

878

(3039443) Prostate specific Ag panel - Serum or Plasma

333

1.05

0.07

1.1

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

0.90

0.07

1.1

100.2

92.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

226

2228

1.02

0.07

2.1

2.8

ng/l

370.6

528.8

0.73

146

1675

(4133840)

1.12

0.06

1.4

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1196

11908

1.01

0.06

3.0

2.9

estimate

0.0

1.31

120

2511

(3034426) Prothrombin time (PT)

119

1.09

0.06

1.6

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

445

0.97

0.05

1.8

—

(4094501)

323

0.96

0.05

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

278

1.04

0.04

1.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.10

0.04

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

182

1800

1.01

0.04

2.7

3.4

pmol/l

4.9

4.7

0.55

148

1630

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

0.94

0.04

1.4

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

191

1930

0.99

0.04

1.2

1.3

u/ml

288.8

234.3

0.25

171

1798

(3017315) Amylase [Enzymatic activity/volume] in Urine

109

0.92

0.04

1.1

1.3

u/l

362.3

408.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2245

22479

0.99

0.03

3.3

3.0

mmol/l

2.9

0.03

2100

21401

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

141

1.06

0.03

1.3

2.3

mg/l

10.6

9.5

—

121

(40760888) Immunoglobulin light chains.free panel - Serum

138

0.94

0.02

1.2

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2236

22381

1.00

0.02

3.1

3.0

mmol/l

4.7

0.00

2100

21476

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

158

1567

1.01

0.02

1.4

1.6

—

(4062490)

248

0.97

0.02

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

107

0.93

0.02

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

312

1.03

0.02

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

155

1.03

0.00

1.1

1.0

nmol/l

503.6

417.3

1.47

148

(3011648) Oxygen content in Venous blood

119

1.01

0.00

3.6

2.4

11.6

11.8

0.04

119

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

161

0.99

0.00

2.4

1.6

101.2

116.3

0.90

154

(3027135) IgG subclass 1 [Mass/volume] in Serum

251

1.00

0.00

1.3

1.4

g/l

6.9

6.6

0.19

166

(3024139) IgG subclass 3 [Mass/volume] in Serum

251

1.00

0.00

1.3

1.4

g/l

0.5

0.4

0.46

164

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

309

1.00

0.00

1.2

1.3

—

251.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

635

1.01

0.00

2.3

2.1

—

(40768441) Liver Pathology biopsy report

134

0.97

0.00

1.9

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

136

1.03

0.00

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

146

1.03

0.00

1.5

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

236

1.02

0.00

1.5

—

(4281824)

128

1.02

0.00

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

148

1.01

0.00

1.1

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

706

1.01

0.00

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

252

0.99

0.00

1.3

1.4

g/l

2.8

3.1

0.25

166

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

728

1.00

0.00

2.1

iu/l

4.3

4.4

0.00

307

(3002385) Erythrocyte distribution width [Ratio]

2185

21847

1.00

0.00

12.0

11.1

13.2

13.3

0.42

2150

21404

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

197

1.02

0.00

1.2

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

5.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.00

0.0

1.3

—

38.5

—

(40758292) HTLV I+II Ab panel - Serum

0.86

0.00

1.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

7.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

216.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

1340

1.00

0.00

1.1

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.90

0.00

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.0

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

35.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.93

0.00

1.6

1.5

g/l

35.2

38.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

86.8

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

6.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

3.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.8

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

14.0

—

2380.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.4

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

13.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.00

0.00

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.91

0.00

7.8

9.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

22.8

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

7.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3045414) Leukocytes [Presence] in Urine

910

1.00

0.00

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

13.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

3.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.7

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.95

0.00

5.1

3.1

u/ml

63.3

42.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

110

1.00

0.00

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.92

0.00

1.6

1.9

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

300

1.00

0.00

1.1

1.0

u/ml

0.7

0.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(21494434) Karyotype in Bone marrow

0.95

0.00

1.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_CHLAMYDIA_OTHER and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_CHLAMYDIA_OTHER	1.411 [1.1, 1.82]	0.008
Birth year	0.995 [0.99, 1.0]	0.24

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 13290 females with AB1_CHLAMYDIA_OTHER died.

Males

Parameter	HR [95% CI]	p-value
AB1_CHLAMYDIA_OTHER	0.867 [0.73, 1.03]	0.111
Birth year	0.985 [0.98, 0.99]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 186 out of 11756 males with AB1_CHLAMYDIA_OTHER died.

Mortality risk

Mortality risk for people of age

years, who have AB1_CHLAMYDIA_OTHER.

N-year risk	Females	Males
1	0.143%	0.189%
5	0.803%	1.037%
10	1.932%	2.505%
15	3.446%	4.732%
20	6.382%	7.851%

Relationships between endpoints

↥

Index endpoint: AB1_CHLAMYDIA_OTHER – Other sexually transmitted chlamydial diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other sexually transmitted chlamydial diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints